Showing results (931-940 of 2,378) with videos related to
Sort By:
Pageof 238
Current Opinion in Pharmacology|November 21, 2017
MicroRNAs in intestinal barrier function, inflammatory bowel disease and related cancers-their effects and therapeutic potentialsEsmerina Tili, Jean-Jacques Michaille, Victoria Piurowski, et al.Current Opinion in Pharmacology|November 21, 2017
Clinical pharmacokinetic-pharmacodynamic analyses: a critical element for developing antibacterial agentsSujata M Bhavnani, Jeffrey P HammelCurrent Opinion in Pharmacology|May 26, 2022
Disease-modifying therapies in short bowel syndromeBrune de Dreuille, Francisca JolyCurrent Opinion in Pharmacology|May 11, 2022
COVID-19 and retinal degenerative diseases: Promising link "Kaempferol"Arman Firoz, Priti TalwarCurrent Opinion in Pharmacology|March 17, 2018
Metabotropic glutamate receptors as drug targets for the treatment of absence epilepsyRichard Teke Ngomba, Gilles van LuijtelaarCurrent Opinion in Pharmacology|June 6, 2022
Treatment approach to connective tissue disease-associated interstitial lung diseaseTimothy M Wilson, Joshua J Solomon, M Kristen DemoruelleCurrent Opinion in Pharmacology|June 11, 2022
Mucus-targeting therapies of defective mucus clearance for cystic fibrosis: A short reviewMiriam Frankenthal Figueira, Carla M P Ribeiro, Brian ButtonCurrent Opinion in Pharmacology|June 24, 2022
Functional role of the ER stress transducer IRE1α in CF airway epithelial inflammationCarla M P Ribeiro, Emily A Hull-RydeCurrent Opinion in Pharmacology|July 6, 2022
The changing landscape of the cystic fibrosis lung environment: From the perspective of Pseudomonas aeruginosaMatthew A Greenwald, Matthew C WolfgangCurrent Opinion in Pharmacology|November 15, 2020
Embracing diversity: how can broadly neutralizing antibodies effectively target a diverse HIV-1 reservoir?Andrew Wilson, Rebecca M LynchPageof 238